What is tryptase testing and how is it performed to evaluate mast‑cell activation in a patient with fluctuating fatigue and brain fog?

What is Tryptase Testing?

Tryptase testing is a blood test that measures serum levels of tryptase—a protease enzyme released by mast cells—to evaluate mast cell activation and degranulation, particularly useful in diagnosing anaphylaxis, systemic mastocytosis, and mast cell activation syndrome. 1

Understanding Tryptase Biology

Tryptase exists in two main forms with distinct clinical significance 1, 2:

• α-tryptase: Secreted continuously (constitutively) by mast cells and represents the baseline level found in healthy individuals. Elevated α-tryptase indicates increased mast cell burden, as seen in systemic mastocytosis or hereditary α-tryptasemia.

• β-tryptase: Stored in mast cell granules and released only during degranulation episodes (anaphylaxis, mast cell activation). This is the form that rises acutely during allergic reactions.

The most widely used assay (ImmunoCAP fluorescence enzyme immunoassay) measures total tryptase (α + β combined) 1.

How Tryptase Testing is Performed

For patients with suspected mast cell activation (including those with fluctuating fatigue and brain fog), you must obtain BOTH acute and baseline samples 1, 2, 3:

Timing is Critical

Acute sample (sAT):

• Collect 1-2 hours after symptom onset (optimal window: 30 minutes to 2 hours) 2, 1
• Tryptase peaks at approximately 1 hour and has a half-life of ~2 hours 1
• Can remain elevated up to 5-6 hours after onset 2
• Do not delay resuscitation to obtain the sample 1

Baseline sample (sBT):

• Collect at least 24 hours after complete symptom resolution 1, 3
• Alternatively, can be obtained before any event occurs
• Normal baseline: <8.4 μg/L (some guidelines use <11.4 ng/mL or 1-15 ng/mL range) 4

Interpretation Algorithm

For diagnosing acute mast cell activation (anaphylaxis/MCAS):

• Use the "20 + 2 rule": sAT must exceed (1.2 × sBT) + 2 μg/L 3, 4
• Alternative formula: sAT/sBT ratio ≥1.685 5
• Neither acute nor baseline values alone are sufficient for diagnosis 3

Important caveats:

• Normal tryptase does NOT exclude anaphylaxis—sensitivity is relatively low (~50-80%) 1
• Anaphylaxis from basophil or complement activation may not elevate tryptase 1
• IV fluid resuscitation dilutes tryptase concentrations; account for this when interpreting results 1

Clinical Applications for Your Patient

For a patient with fluctuating fatigue and brain fog, tryptase testing serves multiple purposes:

1. Baseline Tryptase Evaluation

• If sBT >20 μg/L: Minor criterion for systemic mastocytosis; requires bone marrow evaluation 4, 6
• If sBT 8-20 μg/L: Consider hereditary α-tryptasemia (present in 4-8% of population), associated with dysautonomia, POTS, gastrointestinal symptoms, and fatigue 3, 7
• If sBT <8 μg/L: Normal mast cell burden

2. Documenting Episodic Activation

If symptoms occur in discrete episodes:

• Obtain acute sample during symptomatic period (within 1-2 hours of onset)
• Compare to baseline using 20 + 2 rule
• Mast Cell Activation Syndrome (MCAS) requires: recurrent symptoms involving ≥2 organ systems + documented tryptase elevation meeting the 20 + 2 criterion 4, 6

3. Differential Diagnosis

Elevated baseline tryptase can also occur in 4, 6:

• Chronic kidney disease
• Obesity
• Hematological malignancies
• These conditions require different management approaches

Practical Testing Strategy

For your patient with fluctuating symptoms:

1. Start with baseline tryptase when patient is asymptomatic and >24 hours from last episode
2. If baseline is elevated (>8 μg/L): Pursue workup for hereditary α-tryptasemia or systemic mastocytosis
3. If symptoms are episodic: Provide patient with instructions to present for acute blood draw within 1-2 hours of symptom onset
4. If symptoms are continuous/fluctuating without clear episodes: Baseline tryptase alone may identify underlying mast cell conditions but won't capture activation events

Key Limitations

• High specificity (>90%) but variable sensitivity 1, 3—many true anaphylactic reactions have normal tryptase
• Sensitivity correlates with clinical severity, particularly hypotension 3
• Cannot distinguish allergic from non-allergic anaphylaxis 1
• Some patients release histamine without tryptase elevation 2

The evidence consistently emphasizes that tryptase is most useful when both acute and baseline values are compared, not as a standalone test 3, 8. For chronic symptoms like fatigue and brain fog without clear acute episodes, baseline tryptase primarily screens for underlying mast cell disorders rather than documenting activation events.